Sagent Pharmaceuticals Issues Voluntary Nationwide Recall of Docetaxel Injection, USP Due to Potential Presence of Particulate Matter

Summary Company Announcement Date: May 28, 2024 FDA Publish Date: May 29, 2024 Product Type: Drugs Reason for Announcement: Recall Reason Description Potential presence of particulate matter Company Name: Sagent Pharmaceuticals Brand Name: Brand Name(s) Product Description: Product Description Docetaxel Injection, USP Company Announcement FOR IMMEDIATE RELEASE – SCHAUMBURG, IL – May 28, 2024 –…

Hologic, Inc. Recalls BioZorb Marker Due to Complications with Implanted Devices

The FDA has identified this as a Class I recall, the most serious type of recall. Use of these devices may cause serious injuries or death.  Please be aware, this recall is a correction, not a product removal.   Recalled Product  Product Names: BioZorb Marker Product Codes: NEU  Model Numbers:  F0405 BioZorb Marker 4cm x…

Hospira Inc. Issues A Voluntary Nationwide Recall For Buprenorphine Hydrochloride Injection CarpujectTM Units and Labetalol Hydrochloride Injection, USP CarpujectTM Units Due to the Potential for Incomplete Crimp Seals

Summary Company Announcement Date: May 21, 2024 FDA Publish Date: May 22, 2024 Product Type: Drugs Reason for Announcement: Recall Reason Description Device & Drug Safety – Potential Packaging Defect Company Name: Hospira Inc. Brand Name: Brand Name(s) Product Description: Product Description Buprenorphine Hydrochloride Injection Carpuject Units and Labetalol Hydrochloride Injection, USP Carpuject Units Company…

Safety and Quality Concerns with Getinge Cardiovascular Devices – Letter to Health Care Providers

May 8, 2024 The U.S. Food and Drug Administration (FDA) is alerting health care providers and facilities about our continued safety and quality concerns with the following Getinge/Maquet cardiovascular medical devices: Getinge/Maquet/Datascope Cardiosave Hybrid and Rescue Intra-Aortic Balloon Pump (IABP) devices and Getinge/Maquet Cardiohelp system and HLS Sets. The FDA recommends that health care facilities…

MEGADYNE™ Initiates Global Discontinuation and Voluntary Recall of MEGA SOFT™ Pediatric Patient Return Electrode

Summary Company Announcement Date: May 10, 2024 FDA Publish Date: May 10, 2024 Product Type: Medical Devices Reason for Announcement: Recall Reason Description Reports of patient burn injuries Company Name: Megadyne Medical Products Inc. Brand Name: Brand Name(s) Ethicon Megadyne Product Description: Product Description Mega Soft Pediatric Patient Return Electrode Company Announcement Cincinnati, OH –…